S&D Co (260970) Q2 2025 earnings summary

Executive summary

• Specializes in functional food ingredients and health supplements, with diversification into natural materials for cosmetics and household goods.

• Maintains strong domestic sales, with all products sold via direct B2B channels; no current overseas sales but preparing for international expansion.

• Holds 31 patents and continues to invest in R&D, focusing on functional food ingredients and natural health solutions.

Financial highlights

• 2025 H1 revenue: KRW 73.8 billion, down from KRW 116.1 billion in FY2024.

• Operating income for 2025 H1: KRW 11.4 billion; net income: KRW 9.3 billion.

• Basic EPS for 2025 H1: KRW 3,222.

• Total assets as of June 2025: KRW 106.5 billion; equity: KRW 75.1 billion.

• Cash and cash equivalents at period end: KRW 15.4 billion.

Outlook and guidance

• Actively pursuing business diversification and new business opportunities, with recent additions to business purposes in the articles of incorporation.

• Ongoing investments in production capacity and facility expansion to support future growth.